PEspeaks

May 04, 2016
Pharmaceutical Executive
The Boston biotech cluster proved an ideal setting for Pharm Exec's recent annual Editorial Advisory Board meeting. William Looney reports.
May 03, 2016
From Applied Clinical Trials
Amidst arguments that industry is heading for another economic recession, Moe Alsumidaie reminds us that biopharma has shown resiliency during such times.
Apr 27, 2016
Pharmaceutical Executive
Policymakers seek to limit prescribing while also encouraging innovative R&D.
Apr 26, 2016
Facebook is the number one social-media network for businesses. Peter Houston asks, How can pharma stay relevant in the feed?
Apr 11, 2016
The American College of Physicians has chimed in on the debate surrounding prescription drug costs, offering its views for stemming the escalation.
Apr 01, 2016
In many life situations, it’s difficult to be hopeful. But at SxSW Interactive last month, it was difficult to be pessimistic, writes Bill Drummy.
Apr 01, 2016
Peter Young examines the drivers affecting the biotech industry in 2015, and what to expect in 2016.
Mar 31, 2016
Twitter, recently turned ten years old, has earned a seat at the top table of digital media. But exactly where it sits for marketers remains somewhat uncertain, writes Peter Houston.
Mar 29, 2016
Deep in the massive bureaucracy of the United Nations is an undertaking that appears to have been conceived and designed to be combative — and biopharma may be the target. Stephen Tepp reports.
Mar 21, 2016
NICE's notion to charge the industry for its technology appraisals looks set to become reality, writes Leela Barham.
lorem ipsum